Turning CAR-T tech against solid tumors by targeting protein fragments in cancer cells – FierceBiotech

CAR-T therapies, which arm a patients own immune cells with cancer-fighting proteins, are currently used to treat some patients with blood cancers. But the technology has been hard to apply to other cancers, partly because of a lack of tumor-specific antigens…

Click here to view the original article.